“The U.S. Court of Appeals for the D.C. Circuit reversed the dismissal of a lawsuit that contends the Obama administration’s embryonic stem cell research policy violates federal law. The court found that the plaintiffs have ‘competitive standing’ to sue.” More at Christian Post
